KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Announces U.S. Launch of Large Fragment Cannulated Screw System

OrthoPediatrics Corp. Announces U.S. Launch of Large Fragment Cannulated Screw System

WARSAW, Ind., March 09, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the limited U.S. launch of its Large Fragment Cannulated Screw System, which would represent the Company’s 34th surgical system. The innovative system was designed to address trauma procedures, as well as treating children with a condition known as Slipped Capital Femoral Epiphysis (“SCFE”) and includes specific design elements to address the unique needs of the pediatric population.

These unique design features include:

-  Screws in 2mm increments for more precision

-  Screw thread run out in the head of screw to aid in hardware removal

-  Dual lead threads to accelerate screw insertion

-  Threaded cannulation to facilitate implant removal

Large Fragment Cannulated Screws (available in 6.5mm and 7.3mm diameters) are intended for pediatric fracture fixation of large bones and large bone fragments such as slipped capital femoral epiphysis, femoral neck fractures, tibial plateau fractures, sacroiliac joint disruption, intercondylar femur fractures, subtalar arthrodesis and fixation of pelvis and iliosacral joint.

Jeff Mebel, OrthoPediatrics’ Trauma Product Director, commented, “We are excited about the domestic beta release of our new Large Fragment system and look forward to supporting physician adoption. This launch represents our continued commitment to provide our surgeon customers with innovative technology to treat a wide variety of pathologies that are unique to children. We have the privilege of partnering with excellent physicians and their input has represented a valuable part in bringing this system to market.”

The OrthoPediatrics development team worked closely with four pediatric orthopedic surgeons from prominent institutions globally on the design of the screw implants and instruments. Dr. Scott Hoffinger, pediatric orthopedic surgeon in San Francisco, shared his interest in the platform, stating, “The engineering group at OrthoPediatrics completely reconfigured the screw system and precisely designed it specifically for the pediatric patient. This will help overcome challenges we encounter in the operating room every day.” 

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 34 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit .

Investor Contacts

The Ruth Group

Tram Bui / Emma Poalillo

(646) 536-7035 / 7024

/

EN
09/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results an...

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-year WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       He...

 PRESS RELEASE

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Braci...

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories. The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and ...

 PRESS RELEASE

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Ann...

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 45th Canaccord Genuity Annual Growth Conference, held in Boston, MA. Event: 45th Canaccord Genu...

 PRESS RELEASE

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip Sys...

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip System, used to treat proximal femur fractures and deformities. “The 3P Pediatric Plating Platform Hip System is an exceptional product that would not be possible without our remarkable desi...

 PRESS RELEASE

OrthoPediatrics Corp. to Report Second Quarter Financial Results on Au...

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025 WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch